Change history
29 May 2014
In the version of this article initially published, Genentech's compound Taselisib was incorrectly labeled as Pictilisib in Table 1. The error has been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fox, J. Master Protocol for squamous cell lung cancer readies for launch. Nat Biotechnol 32, 116–117 (2014). https://doi.org/10.1038/nbt0214-116b
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0214-116b
- Springer Nature America, Inc.